Efficacy - Cosentyx PsA
Reimbursement - Cosentyx PsA
Mechanism of action - Cosentyx PsA
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources - Cosentyx PsA
Dosing - Consentyx PsA
Useful tools & Links - Hematology
Patient websites and organizations
Belgian Hematology Society (BHS)The Belgian Hematology Society (BHS) is a...
Twitter Linkedin Facebook Pinterest Google plusSafety Profile - Entresto
ENTRESTO ® demonstrated comparable safety and tolerability vs EnalaprilTwitter Linkedin Facebook Pinterest Google plusDosing - Entresto
Dose regimen Oral use Twice daily dose. Can be taken with or without food; The tablets must be swallowed with a glass of water. Tablet strength makes interim dose adjustment easy. If a dose is missed, the patient should take the next...Twitter Linkedin Facebook Pinterest Google plusReimbursement / eHealth - Entresto
Entresto ® is reimbursed for the treatment of adult patients with chronic heart failure with reduced ejection fraction in Belgium.
Twitter Linkedin Facebook Pinterest Google plus
